Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 1 of 1 for:    NCT01504347
Previous Study | Return to List | Next Study

Phase 1/2 Lyme Vaccine Study

This study has been completed.
Baxter Innovations GmbH
Information provided by (Responsible Party):
Baxter Healthcare Corporation Identifier:
First received: December 22, 2011
Last updated: March 25, 2014
Last verified: March 2014